TP53 and breast cancer: Notably, our findings indicate that p53 expression can be used to identify a p53+ luminal A-like breast cancer phenotype that is characterized by younger age at onset, high KI67 proliferation index, high EGFR expression, as well as associations with parity and breastfeeding practices.